Smithers has accumulated more than four decades of expertise in organising global events and curating enlightening and informative conferences that offer valuable networking prospects.
Attended by CEO's, senior principal scientists, researchers, presidents, chemistry directors, lecturers, R&D managers and pharmacologists to name a few.
The event spans over two days and includes a series of presentations on industry insights and collaborative discussions, making it an indispensable gathering for professionals working within the industry.
We explore topics such as.png)
Dr. Valeria Mazzoni, graduated in Industrial Biotechnology in 2015 at the University of Milan Bicocca, working for 2 years as a researcher at the same university. She obtained a master's degree in food quality in 2016 and has been working in Neotron since 2017, gaining experience in the R&D and packaging department (food and Pharma). From 2024 is the head of the E&L Unit of Neotron.
Alessio Mastrovito is a research scientist part of the Vantive E&L EU team. After his MSc in Industrial Chemistry at Bologna University, he worked as Analytical Chemist at a third-party lab conducting chemical testing on a wide range of medical devices, focusing on chemical characterization and ethylene oxide sterilization residuals analysis (according to ISO 10993 parts 7 and 18). He joined Vantive in 2021 as E&L SME, being key figure within a number of sustaining product and MDR remediation activities, acquiring experience on many products of the PD, HD and Acute portfolio.
Ron Brown is a toxicologist with 35 years of experience in regulatory toxicology and risk assessment. He recently retired from the US FDA after 25 years of service and currently directs a small company, Risk Science Consortium, LLC, that provides consultation and training in toxicological risk assessment and computational toxicology. At the FDA, Ron was the senior toxicologist responsible for developing and reviewing toxicological risk assessments of extractable and leachable (E&L) compounds from medical devices. Prior to his position at the US FDA, Ron served as a Senior Associate at the ILSI Risk Science Institute. He is founding member and former President of the Medical Device and Combination Products Specialty Section of the Society of Toxicology and former President of the Dose-Response Specialty Section of the Society for Risk Analysis.
Trish joined Pfizer in February 2020 as a Global Risk Assessment Services Toxicologist in Drug Safety R&D. Trish has a background in Genetic Toxicology and over the last 12 years has built expertise in mutagenic impurity, extractable and leachable, and contamination risk assessments. In recent years, Trish participated in ICH M7 working group to develop Appendix 3 and co-authored hydrogen peroxide monograph. In addition, she authored the vinyl acetate monograph in the subsequent publication Bercu et al., (2018). Trish is also the co-chair of the Extractables and Leachables Safety Information Exchange (ELSIE) PDE and Sensitisation Sub-teams and is an active member of the EFPIA working group to support ICHQ3E.
Julia Martins has a strong academic and professional background in toxicological sciences, having earned a PhD in the field. Her expertise in analytical chemistry is supported by her master's degree, further strengthening her scientific foundation. Julia's extensive experience as a toxicologist in the pharmaceutical industry in Brazil has solidified her proficiency in toxicological assessments. Over the years, she has gained in-depth knowledge of regulatory guidelines and the evaluation of multiple toxicity endpoints within the context of toxicological risk assessments. Julia is currently a Scientist at Lhasa Limited where she contributes to the development of computational solutions for impurity assessment and read-across methodologies, including extractables and leachables (E&L) safety assessment.
Thomas Egert is a research scientist at Boehringer Ingelheim, Germany. Dedicated to analytical chemistry for 20+ years, his current role includes responsibility for materials selection and E&L qualification as well as analytical troubleshooting during packaging development.
Thomas is an active member of the Extractables and Leachables Safety Information Exchange Consortium (ELSIE) and the PQRI Parenteral and Ophthalmic Drug Product (PODP) – E&L Working Group. While contributing to several industry seminars in the field of pharmaceutical packaging, his special interest is devoted to predictive physico-chemical models for mass transfer from primary contact materials into pharmaceuticals.
Prior to joining Boehringer Ingelheim, Thomas held various positions in the field of organic trace analysis at an analytical service provider. Thomas holds a diploma in chemical engineering and a master’s degree in bio- and pharmaceutical analysis.
